UroGen Pharma(URGN) - 2025 Q4 - Earnings Call Transcript

UroGen Pharma (NasdaqGM:URGN) Q4 2025 Earnings call March 02, 2026 10:00 AM ET Company ParticipantsChris Degnan - CFODavid Lin - Chief Commercial OfficerElizabeth Barrett - President, CEO, and DirectorMark P. Schoenberg - Chief Medical OfficerVincent Perrone - Senior Director of Investor RelationsConference Call ParticipantsAydin Huseynov - Managing Director and Senior Biotechnology AnalystKelsey Goodwin - Senior Healthcare Equity Research AnalystLeland Gershell - Managing Director and Senior AnalystMichael ...